Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Acetaminophen and Tramadol Combination BID Versus Placebo for the Treatment of Acute Low Back Pain

ClinicalTrials.gov ID: NCT00643383

Public ClinicalTrials.gov record NCT00643383. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 10:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A multi-center placebo controlled, double-blind, trial comparing the analgesic efficacy and safety of Acetram Contramid® BID versus placebo for the treatment of acute low back pain in patients between 18 and 80 yrs of age.

Study identification

NCT ID
NCT00643383
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Labopharm Inc.
Industry
Enrollment
277 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2008
Primary completion
Dec 31, 2008
Completion
Jan 31, 2009
Last update posted
Apr 30, 2012

2008 – 2009

United States locations

U.S. sites
18
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Not listed Montgomery Alabama 36117
Not listed Centennial Colorado 80112
Not listed Hialeah Florida 33013
Not listed Largo Florida 33770
Not listed New Port Richey Florida 34652
Not listed Indianapolis Indiana 46254
Not listed Waterloo Iowa 50702
Not listed Baton Rouge Louisiana 70809
Not listed Brockton Massachusetts 02301
Not listed Minneapolis Minnesota 55415
Not listed Oklahoma City Oklahoma 73112
Not listed Rapid City South Dakota 57702
Not listed Crossville Tennessee 38555
Not listed Bryan Texas 77082
Not listed Dallas Texas 75235
Not listed Houston Texas 77074
Not listed Salt Lake City Utah 84109
Not listed Salt Lake City Utah 84121

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00643383, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 30, 2012 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00643383 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →